Cvs Health CORP 13F institutional holdings
Quarterly disclosures of US equity positions held by institutional managers with over $100 million under management.
NYSE
CVS HEALTH Corp reported 21 holdings worth $225.2M for the period ended June 30, 2026.
NYSE
CVS Health Corp. has filed its quarterly 13F holdings report, detailing its investment portfolio as of March 31, 2026, with a total reported value of $212,255,190.
NYSE
CVS Health Corp. filed its Form 13F-HR, revealing over $102 million in equity holdings as of September 30, 2025.
NYSE
CVS Health Corp. has filed its Q2 2025 13F report, revealing equity holdings totaling over $190 million, primarily in the SPDR S&P 500 ETF Trust.
NYSE
CVS Health Corp's latest 13F filing discloses its holdings as of March 31, 2025, showcasing investments in Prudential Financial, Health Catalyst, and SPDR S&P 500 ETF Trust.
NYSE
CVS Health Corp's recent 13F filing reveals its holdings in Prudential Financial, Health Catalyst, and SPDR S&P 500 ETF Trust as of December 31, 2024.
NYSE
CVS Health Corp's latest 13F filing discloses approximately $230 million in managed securities as of September 30, 2024.
NYSE
CVS Health Corp's latest 13F filing reveals its investment holdings as of June 30, 2024, totaling $216.8 million across six positions.
NYSE
CVS Health Corp's latest 13F filing discloses $211.8 million in managed securities as of March 31, 2024, with significant positions in SPDR S&P 500 ETF Trust and Vanguard Whitehall Fds.